Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica D Pratt

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
JAMA Network Open|October 10, 2025
Air Purifier Intervention for Respiratory Viral Exposure in Elementary Schools: A Secondary Analysis of a Randomized Clinical TrialYe Sun, Dastan Haghnazari, Ching-Ying Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
JAMA Network Open|October 10, 2025
Air Purifier Intervention for Respiratory Viral Exposure in Elementary Schools: A Secondary Analysis of a Randomized Clinical TrialYe Sun, Dastan Haghnazari, Ching-Ying Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Nature Communications|November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistanceAmy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Pageof 2